Arvest Bank Trust Division’s Bristol-Myers Squibb BMY Stock Holding History

Arvest Bank Trust Division’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$837K	Buy	13,793 +740	+6%	+$43.1K	0.05%	144
2025 Q4	$704K	Buy	13,053 +875	+7%	+$42.1K	0.04%	143
2025 Q3	$549K	Buy	12,178 +804	+7%	+$37.5K	0.03%	153
2025 Q2	$527K	Sell	11,374 -21,403	-65%	-$1.05M	0.03%	138
2025 Q1	$2M	Buy	32,777 +324	+1%	+$18.9K	0.13%	92
2024 Q4	$1.84M	Sell	32,453 -867	-3%	-$48.4K	0.11%	95
2024 Q3	$1.72M	Buy	+33,320	New	+$1.56M	0.1%	97
2021 Q3	$854K	Buy	14,440 +4,169	+41%	+$275K	0.05%	100
2021 Q2	$686K	Buy	+10,271	New	+$670K	0.04%	107

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arvest Bank Trust Division's BMY Position: Q1 2026 in Review

Arvest Bank Trust Division increased its Bristol-Myers Squibb (BMY) stake by 5.7% in Q1 2026, buying an estimated $43.1K and bringing the position to 13,793 shares worth $837K. The position accounts for 0.05% of the portfolio, ranked #144.

Arvest Bank Trust Division first reported a position in BMY in Q2 2021 and has held it in 9 quarters since. The position peaked at $2M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Arvest Bank Trust Division held 13,793 shares of Bristol-Myers Squibb worth $837K as of Q1 2026.
Arvest Bank Trust Division bought 740 Bristol-Myers Squibb shares in Q1 2026, an estimated $43.1K.
Bristol-Myers Squibb made up 0.05% of Arvest Bank Trust Division's portfolio in Q1 2026, its #144 holding.
Arvest Bank Trust Division first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 9 quarters since.
Arvest Bank Trust Division's Bristol-Myers Squibb position peaked at $2M in Q1 2025.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Arvest Bank Trust Division's 13F filing for Q1 2026, filed 13 May 2026.